Cochesa, Jenna J.

HRN: 12-13-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2022
CEFUROXIME 750MG (VIAL)
09/17/2022
09/24/2022
IV
560 Mg
Q8H
UTI
Waiting Final Action 
09/23/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/23/2022
09/30/2022
IV
85 Mg
Q8
UTI
Waiting Final Action 
09/25/2022
CEFTRIAXONE 1G (VIAL)
09/22/2022
09/29/2022
IV
845
Q12
Typhoid Fever
Waiting Final Action 
09/26/2022
CIPROFLOXACIN 500MG (TAB)
09/26/2022
10/03/2022
ORAL
1/2 Tab
12 Hrs
Typhoid Fever
Waiting Final Action 
09/30/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
09/30/2022
10/26/2022
ORAL
4.5 Ml
24 Hrs
Typhoid Fever; Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: